Portrait of happy young black woman relaxing on wooden deck chair at tropical beach while looking at camera wearing spectacles. Smiling african american girl with fashion sunglasses enjoying vacation.

Celltrion Completes Application for FDA Approval of CT-P41, Biosimilar of Prolia® / Xgeva®

Start
On November 30, 2023, Celltrion announced that it filed for an abbreviated Biologics License Application (aBLA) for FDA approval of CT-P41 (denosumab), a proposed biosimilar of Amgen’s Prolia® / Xgeva® (denosumab)……
By: Venable LLP
Previous Story

Chinese Issuers See Progress on US Audit Issue and HKEX Reforms, but US Policies Could Impact Tech Companies

Next Story

Year-End Review – Data Privacy Insights To Take into 2024